HOXA1-IN-1

Overview

HOXA1-IN-1 is a HOXA1 inhibitor. HOXA1-IN-1 downregulates HOXA1 protein levels, suppresses its transcriptional activity, and alters the expression of its downstream target genes. HOXA1-IN-1 induces DNA damage and apoptosis in cancer cells. HOXA1-IN-1 exhibits antitumor efficacy in xenograft models of colorectal cancer and triple-negative breast cancer . HOXA1-IN-1 shows synergistic activity in combination with Cisplatin ( HY-17394 ). HOXA1-IN-1 can be used for the research of colorectal cancer and triple-negative breast cancer .

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Triple-Negative Breast Cancer | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HOXA | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-181823
• CAS No.: 3118854-61-5
• Molecular Formula: C23H31NO2
• Molecular Weight: 353.50
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source